Because the peptide works specifically on fat tissue without affecting other systems, protocols can be designed purely around fat metabolism optimization without concerns about managing glucose, IGF-1, or growth-related effects
However, one limitation of using mitochondrial dysfunction as a diagnostic biomarker for ME/CFS is that other diseases such as fibromyalgia [56, 102], metabolic syndrome, cardiovascular diseases, cancer [103] and neurological disorders (such as Parkinsons [104] and Alzheimers disease [105,106,107]) are also associated with mitochondrial dysfunction
Tirzepatide is available as Mounjaro (indicated for type 2 diabetes) and Zepbound (indicated for chronic weight management)
Effect of canagliflozin on renal and cardiovascular outcomes across different levels of albuminuria: data from the CANVAS Program
Both IPGTT (Figures 5AC) and ITT (Figures 5DF) confirmed glucose metabolic imbalance in obesity, including increased fasting blood glucose (FBG), impaired glucose tolerance, and decreased insulin sensitivity
The benefits of Semaglutide treatment are multifaceted, making it a valuable option for individuals struggling with diabetes and obesity
